Literature DB >> 12708907

An unusual case of recurrent Loffler endomyocarditis of the aortic valve.

G Steinar Gudmundsson1, Joseph Ohr, Ferdinand Leya, William R Jacobs, John E Godwin, Jeffrey Schwartz.   

Abstract

Idiopathic hypereosinophilic syndrome is a rare systemic disease with an unexplained elevated eosinophil count. Loffler endomyocarditis is hypereosinophilic syndrome with endocardial fibrosis and restrictive cardiomyopathy. The atrioventricular valves are frequently involved, causing valvular regurgitation. Previously, there has been one case report of combined aortic and mitral valve involvement with Loffler endomyocarditis that was treated with bivalvular replacement. We describe a previously healthy 50-year-old man diagnosed with Loffler endomyocarditis complicated by peripheral thromboembolism and severe aortic regurgitation due to valve fibrosis and fibrotic vegetation on the aortic valve. He underwent embolectomy and aortic valve replacement in addition to treatment for his hypereosinophilia. He later presented with cardiomyopathy with severe aortic insufficiency due to the destruction of the aortic valve prosthesis by sterile fibrinous vegetation. To our knowledge, this is the second case in the literature in which Loffler endomyocarditis involves the aortic valve and the first patient in whom only the aortic valve is involved.

Entities:  

Mesh:

Year:  2003        PMID: 12708907     DOI: 10.5858/2003-127-0606-AUCORL

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  From an isolated right ventricular thrombus to the diagnosis of the hypereosinophilic syndrome.

Authors:  Shokoufeh Hajsadeghi; Mitra Chitsazan; Hamid Reza Pouraliakbar; Alireza Sadeghipour
Journal:  J Cardiol Cases       Date:  2011-03-27

Review 2.  Unusual case of aortic valve involvement in patient with Löffler's endomyocarditis: management, follow-up and short review of the literature.

Authors:  Evin Bozcali; Farid Aliyev; Mustafa Tarik Agac; Hakan Erkan; Baris Okcun; Erhan Babalik; Hakan Karpuz
Journal:  J Thromb Thrombolysis       Date:  2007-04-05       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.